452 related articles for article (PubMed ID: 30867815)
1. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.
Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y
Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815
[No Abstract] [Full Text] [Related]
2. Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance.
Zhang Y; Dong Y; Fu H; Huang H; Wu Z; Zhao M; Yang X; Guo Q; Duan Y; Sun Y
Biomaterials; 2021 Feb; 269():120478. PubMed ID: 33213862
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
4. Dual-mode US/MRI nanoparticles delivering siRNA and Pt(iv) for ovarian cancer treatment.
Zhang Y; Huang H; Fu H; Zhao M; Wu Z; Dong Y; Li H; Duan Y; Sun Y
RSC Adv; 2019 Oct; 9(57):33302-33309. PubMed ID: 35529112
[TBL] [Abstract][Full Text] [Related]
5. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
[TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
7. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin-Complexed and cRGD-Conjugated Unimolecular Nanoparticles for Targeted Ovarian Cancer Therapy.
Wang Y; Wang L; Chen G; Gong S
Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27911475
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.
Dhar S; Kolishetti N; Lippard SJ; Farokhzad OC
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1850-5. PubMed ID: 21233423
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer.
Patel NR; Piroyan A; Nack AH; Galati CA; McHugh M; Orosz S; Keeler AW; O'Neal S; Zamboni WC; Davis B; Coleman TP
Mol Pharm; 2016 Jun; 13(6):1996-2009. PubMed ID: 27170232
[TBL] [Abstract][Full Text] [Related]
11. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
12. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
13. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.
Ling X; Tu J; Wang J; Shajii A; Kong N; Feng C; Zhang Y; Yu M; Xie T; Bharwani Z; Aljaeid BM; Shi B; Tao W; Farokhzad OC
ACS Nano; 2019 Jan; 13(1):357-370. PubMed ID: 30485068
[TBL] [Abstract][Full Text] [Related]
14. Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer.
Sun Y; Shi T; Zhou L; Zhou Y; Sun B; Liu X
J Microencapsul; 2017 Nov; 34(7):675-686. PubMed ID: 29027828
[TBL] [Abstract][Full Text] [Related]
15. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
17. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
[TBL] [Abstract][Full Text] [Related]
18. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
19. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanoplatforms as cascade-responsive drug-delivery carriers for effective synergistic chemo-photodynamic cancer treatment.
Li F; Liang Y; Wang M; Xu X; Zhao F; Wang X; Sun Y; Chen W
J Nanobiotechnology; 2021 May; 19(1):140. PubMed ID: 34001157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]